Knowledge Hub

Complete 2015-16 Induced Pluripotent Stem Cell (iPSC) Industry Report

Press release   •   Jul 29, 2016 06:25 EDT

p { margin-bottom: 0.25cm; line-height: 120%; }a:link { }

Recent months have seen the first iPSC clinical trial in humans, creation of the world’s largest iPSC biobank, major funding awards, a historic challenge to the “Yamanaka Patent”, a Supreme Court ruling affecting industry patent rights, announcement of an iPSC cellular therapy clinic scheduled to open in 2019, and much more. Furthermore, iPSC patent dominance continues to cluster in specific geographic regions, while clinical trial and scientific publication trends give clear indicators of what may happen in the industry in 2015 and beyond. Is it worth it to get informed about rapidly-evolving market conditions and identify key industry trends that will give you an advantage over your competition?

REPORT APPLICATIONS

This global strategic report is produced for:

Management of Stem Cell Product Companies

Management of Stem Cell Therapy Companies

Stem Cell Industry Investors

It is designed to increase your efficiency and effectiveness in:

Commercializing iPSC products, technologies, and therapies

Making intelligent investment decisions

Launching high-demand products

Selling effectively to your client base

Increasing revenue

Taking market share from your competition

OVERVIEW

Stem cell research and experimentation have been in process for well over five decades, as stem cells have the unique ability to divide and replicate repeatedly. In addition, their “unspecialized” nature allows them to differentiate into a wide variety of specialized cell types. The possibilities arising from these characteristics have resulted in great commercial interest, with potential applications ranging from the use of stem cells in reversal and treatment of disease, to targeted cell therapy, tissue regeneration, pharmacological testing on cell-specific tissues, and more.

Traditionally, scientists have worked with both embryonic and adult stem cells for research tools, as well as for cellular therapy. While the appeal of embryonic cells has been their ability to differentiate into any type of cell, there has been significant ethical, moral, and spiritual controversy surrounding their use. Although some adult stem cells do have differentiation capacity, it is often limited in nature, which results in fewer options for use.

Thus, induced pluripotent stem cells represent a promising combination of adult and embryonic stem cell characteristics.

Download Sample Copy of This Report at: http://www.marketresearchreports.biz/sample/sample/288620